Skip to main content
SpringerLink
Log in

Hepatic Surgery for Metastatic Gastrointestinal Neuroendocrine Tumors

  • Conference paper
Book cover Liver and Pancreatic Diseases Management

Part of the book series: Advances in Experimental Medicine and Biology ((volume 574))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wong WJ, DeCosse JJ. Cytoreductive surgery. Surg Gynecol Obstet. 1990;170:276–281.

    PubMed  CAS  Google Scholar 

  2. Moertel CG. An odyssey in the land of small tumors. J Clin Oncol. 1987;5:1503–1522.

    Google Scholar 

  3. Moertel CG, Sauer WG, Dockerty MB, Baggenstoss AH. Life history of the carcinoid tumor of the small intestine. Cancer. 1961;14:901–912.

    Article  PubMed  CAS  Google Scholar 

  4. Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Iset cell carcinoma of the pancreas: a twenty year experience. Surgery. 1988;104:1011–1017.

    PubMed  CAS  Google Scholar 

  5. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg. 1992;215:8–18.

    PubMed  CAS  Google Scholar 

  6. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg. 1995;169:36.

    Article  PubMed  CAS  Google Scholar 

  7. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 1990;108:1091–1096.

    PubMed  CAS  Google Scholar 

  8. Cozzi PJ, England R, Morris DL. Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors. Cancer. 1995;76:501–509.

    Article  PubMed  CAS  Google Scholar 

  9. Bilchik AJ, Sarantou T, Foshag LJ, Giuliano AE, Ramming KP. Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery. 1997;122:1040–1047.

    Article  PubMed  CAS  Google Scholar 

  10. McDonald ML, Nagorney DM, Connolly HM, Nisimura RA, Schaff HV. Carcinoid heart disease and carcinoid syndrome: successful surgical treatment. Ann Thorac Surg. 1999;67:537–539.

    Article  PubMed  CAS  Google Scholar 

  11. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma. Transplantation. 1998;66:1307–1312.

    Article  PubMed  CAS  Google Scholar 

  12. Kelsen DG, Cheng E, Kemeny H. Streptozotocin and adriamycin in the treatment of APUD tumors. Proc Am Assoc Cancer Res. 1982;23:433.

    Google Scholar 

  13. Oberg K. Advances in chemotherapy and biotherapy of endocrine tumors. Curr Opin. 1998;10:58–65.

    CAS  Google Scholar 

  14. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1992;326:519–523.

    Article  PubMed  CAS  Google Scholar 

  15. Kvols LK. Therapy of malignant carcinoid syndrome. Endocrinol Metab Clin North Am. 1989;18:557–568.

    PubMed  CAS  Google Scholar 

  16. Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med. 1994;120:302–309.

    PubMed  CAS  Google Scholar 

  17. Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68:227–232.

    Article  PubMed  CAS  Google Scholar 

  18. Eriksson B, Oberg K. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook. Ann Oncol. 1999;10:531–538.

    Article  Google Scholar 

  19. Oberg K. Interferon-alpha versus somatostatin or the combination of both in gastroenteropancreatic tumors. Digestion. 1996;57:83.

    Google Scholar 

  20. Kinney MA, Warner ME, Nagorney DM, Rubin J, Schroeder DR, Maxson PM, Warner MA. Perianaesthetic risk and outcomes of abdominal surgery for metastatic carcinoid tumours. Br J Anaesth. 2001 Sep;87(3):497–452.

    Article  Google Scholar 

  21. Stephen JL, Grahame-Smith jDG. Treatment of the carcinoid syndrome by local removal of hepatic metastases. Proc R Soc Med. 1972;65:444–445.

    PubMed  CAS  Google Scholar 

  22. Davis Z, Moertel CG, McIlrath DC. The malignant carcinoid syndrome. Surg Gynecol Obstet. 1973;137:637–644.

    PubMed  CAS  Google Scholar 

  23. Battersby C, Egerton WS. A carcinoid saga. ANZ J Surg. 1974;44:32–84.

    CAS  Google Scholar 

  24. Fotner JG, Kinne DW, Kim DK, Castro EB, Shiu MH, Beattie EJJ. Vascular problems in upper abdominal cancer surgery. Arch Surg. 1974;109:148–153.

    PubMed  CAS  Google Scholar 

  25. Gillett DJ, Smith RC. Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of primary lesion. Am J Surg. 1974;128:95–99.

    Article  PubMed  CAS  Google Scholar 

  26. Kune GA, Goldstein J. Malignant liver carcinoid: the place of surgery and chemotherapy. Review and case presentation. Med J Aust. 1974;2:777–780.

    PubMed  CAS  Google Scholar 

  27. Lannon J. Seventeen cases of hepatectomy. S Afr J Surg. 1974;12:227–232.

    PubMed  CAS  Google Scholar 

  28. Longmire WPJ, Trout HHd, Greenfield J, Tompkins RK. Elective hepatic surgery. Ann Surg. 1974;179:712–721.

    PubMed  Google Scholar 

  29. Reiss R, Antal SC. Indications for partial hepatectomy in metastatic disease. Bull Soc Int Chir. 1974;33:172–177.

    PubMed  CAS  Google Scholar 

  30. Aronsen KF, Torp A, Waldenstrom JG. A case of carcinoid syndrome followed for eight years after palliative liver resection. Acta Med Scand. 1976;199:327–329.

    Article  PubMed  CAS  Google Scholar 

  31. Foster JH, Berman MM. Palliative liver resection to relieve symptoms of the malignant carcinoid and other endocrine syndromes. Solid Liver Tumors. Vol. 22. Philadelphia: W. B. Saunders Company 1977;235–245.

    Google Scholar 

  32. Taylor B, Langer B, Falk RE, Ambus U. Role of resection in the management of metastases to the liver. Can J Surg. 1983;26:215–217.

    PubMed  CAS  Google Scholar 

  33. Thompson HH, Tompkins RK, Longmire WPJ. Major hepatic resection: a 25-year experience. Ann Surg. 1983;197:375–387.

    Article  PubMed  CAS  Google Scholar 

  34. Norton JA, Sugarbaker PH, Doppman JL, et al. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg. 1986;203:352–359.

    PubMed  CAS  Google Scholar 

  35. Stehlin JS, Jr., De Ipoly PD, Greeff PJ, McGaff CJ, Jr., Davis BR, McNary L. Treatment of cancer of the liver. Twenty years’ experience with infusion and resection in 414 patients. Ann Surg. 1988;208:23–35.

    PubMed  Google Scholar 

  36. Akerstrom G, Makridis C, Johansson H. Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol. 1991;30:547–553.

    PubMed  CAS  Google Scholar 

  37. Wolf RF, Goodnight JE, Krag DE, Schneider PD. Results of resection and proposed guidelines for patient selection in instances of noncolorectal hepatic metastases. Surg Gynecol Obstet. 1991;173:454–460.

    PubMed  CAS  Google Scholar 

  38. Dousset B, Saint-Marc O, Pitre J, Sourbrane O, Houssin D, Chapuis Y. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg. 1996;20:908–915.

    Article  PubMed  CAS  Google Scholar 

  39. Berney T, Mentha G, Roth AD, Morel P. Results of surgical resection of liver metastasis from non-colorectal primaries. Br J Surg. 1998;85:1423–1427.

    Article  PubMed  CAS  Google Scholar 

  40. O’Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988;207:373–379.

    PubMed  CAS  Google Scholar 

  41. Makowka L, Tzakis AG, Mazzaferro V, et al. Transplantation of the liver for metastatic neuroendocrine tumors of the intestine and pancreas. Surg Gynecol Obstet. 1989;168:107–111.

    PubMed  CAS  Google Scholar 

  42. Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg. 1989;209:88–98.

    PubMed  CAS  Google Scholar 

  43. Alsina AE, Bartus S, Hull D, Rosson R, Schweizer RT. Liver transplant for metastatic neuroendocrine tumor. J Clin Gastroenterol. 1990;12:533–537.

    PubMed  CAS  Google Scholar 

  44. Gulanikar AC, Kotylak G, Bitter-Suermann H. Does immunosuppression alter the growth of metastatic liver carcinoid after orthotopic liver transplantation? Transplant Proc. 1991;23:2197–2198.

    PubMed  CAS  Google Scholar 

  45. Lobe TE, Vera SR, Bowman LC, Fontanesi J, Britt LG, Gaber AO. Hepaticopancreatidcogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood. J Pediatr Surg. 1992;27:227–229.

    Article  PubMed  CAS  Google Scholar 

  46. Farmer DG, Shaked A, Colonna JOI, et al. Radical resection combined with liver transplantation for foregut tumors. Am Surg. 1993;59:806–812.

    PubMed  CAS  Google Scholar 

  47. Schweizer RT, Alsina AE, Rosson R, Bartus SA. Liver transplantation for metastatic neuroendocrine tumors. Transplant Proc. 1993;25:1973.

    PubMed  CAS  Google Scholar 

  48. Bechstein WO, Neuhaus P. Liver transplantation for hepatic metastases of neuroendocrine tumors. Ann N Y Acad Sci. 1994;733:507–514.

    PubMed  CAS  Google Scholar 

  49. Frilling A, Rogiers X, Knofel WT, Broelsch CE. Liver transplantation for metastatic carcinoid tumors. Digestion. 1994;55:104–106.

    Article  PubMed  Google Scholar 

  50. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995;180:1–9.

    PubMed  CAS  Google Scholar 

  51. Curtiss SI, Mor E, Schwartz ME, et al. The rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg. 1995;180:184–187.

    PubMed  CAS  Google Scholar 

  52. Routley D, Ramage JK, McPeake J, Tan K-C, Williams R. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transplant Surg. 1995;1:118–121.

    Article  CAS  Google Scholar 

  53. Anthuber M, Jauch KW, Briegel J, Groh J, Schildberg FW. Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg. 1996;20:73–76.

    Article  PubMed  CAS  Google Scholar 

  54. Lang H, Oldhafer KJ, Weimann A, et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg. 1997;225:347–354.

    Article  PubMed  CAS  Google Scholar 

  55. Le Treut YP, Delpero JR, Dousset B, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg. 1997;225:355–364.

    Article  PubMed  Google Scholar 

  56. Caplin ME, Hodgson HJ, Dhillon AP, et al. Multimodality treatment for gastric carcinoid tumor with liver metastasis. Am J Gastroenterol. 1998;93:1945–1948.

    Article  PubMed  CAS  Google Scholar 

  57. Hengst K, Nashan B, Avenhaus W, et al. Metastatic pancreatic VIPoma: Deteriorating clinical course and successful treatment by liver transplantation. Z Gastroenterol. 1998;36:239–245.

    PubMed  CAS  Google Scholar 

  58. Savelli G, Chiti A, Spinelli A, et al. Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy. Tumori. 1998;84:82–84.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and General Surgery, Mayo Medical School, Mayo Clinic and Mayo Foundation, Rochester, MN, 55905, USA

    Florencia G. Que, Juan M. Sarmiento & David M. Nagorney

Authors
  1. Florencia G. Que
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan M. Sarmiento
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David M. Nagorney
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial College School of Medicine, Hammersmith Hospital, London, UK

    Nagy A. Habib  & Ruben Canelo  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer

About this paper

Cite this paper

Que, F.G., Sarmiento, J.M., Nagorney, D.M. (2006). Hepatic Surgery for Metastatic Gastrointestinal Neuroendocrine Tumors. In: Habib, N.A., Canelo, R. (eds) Liver and Pancreatic Diseases Management. Advances in Experimental Medicine and Biology, vol 574. Springer, Boston, MA . https://doi.org/10.1007/0-387-29512-7_7

Download citation

Publish with us

Policies and ethics

Search

Navigation